Printed From BioPortfolio.com
GW Pharmaceuticals (GWPH) - Termination of coverage
08:43 EST 24 Nov 2017 | Edison Investment Research
Edison Investment Research - Pharmaceutical & healthcare - GW Pharmaceuticals: Edison Investment Research is terminating coverage on GW Pharmaceuticals (GWPH). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
ISIN: US36197T1034
Original Article: GW Pharmaceuticals (GWPH) - Termination of coverage
